Clinical Trials Browser

NETWORK × Leukemia, Lymphocytic, Chronic, B-Cell × Lenalidomide × Clear all

NCT00628238 2010-09-10

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell